Cargando…
Clinical utility of a molecular signature in inflammatory demyelinating disease
OBJECTIVE: We sought to develop molecular biomarkers of intrathecal inflammation to assist neurologists in identifying patients most likely to benefit from a range of immune therapies. METHODS: We used Luminex technology and index determination to search for an inflammatory activity molecular signat...
Autores principales: | Pachner, Andrew R., DiSano, Krista, Royce, Darlene B., Gilli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278854/ https://www.ncbi.nlm.nih.gov/pubmed/30568998 http://dx.doi.org/10.1212/NXI.0000000000000520 |
Ejemplares similares
-
Central Nervous System Inflammatory Aggregates in the Theiler's Virus Model of Progressive Multiple Sclerosis
por: DiSano, Krista D., et al.
Publicado: (2019) -
Differential neuro-immune patterns in two clinically relevant murine models of multiple sclerosis
por: DiSano, Krista D., et al.
Publicado: (2019) -
Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
por: DiSano, Krista D., et al.
Publicado: (2021) -
SeXX Matters in Multiple Sclerosis
por: Gilli, Francesca, et al.
Publicado: (2020) -
Are CSF CXCL13 concentrations solely dependent on intrathecal production? A commentary on “Chemokine CXCL13 in serum, CSF, and blood–CSF barrier function”
por: DiSano, Krista D., et al.
Publicado: (2021)